MedBright AI Investments Achieves 77.78% Return, NexgenRx Declines by 2.35%
MedBright AI Investments, Inc. has emerged as a standout performer in the Micro Cap category, achieving a remarkable 77.78% return over the past six months, driven by its operations in the Finance sector. In contrast, NexgenRx, Inc. has faced challenges, posting a -2.35% return in the Miscellaneous sector. This disparity highlights the inherent volatility and potential for significant gains within smaller market segments, suggesting that while opportunities exist, investors should remain vigilant and conduct thorough research before investing.
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
